ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
23.40
-1.39 (-5.61%)
At close: Mar 6, 2026, 4:00 PM EST
23.03
-0.37 (-1.58%)
After-hours: Mar 6, 2026, 7:20 PM EST
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $209.84 million as of March 6, 2026. Its market cap has increased by 632.81% in one year.
Market Cap
209.84M
Enterprise Value
194.41M
1-Year Change
632.81%
Ranking
Category
Stock Price
$23.40
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $209.84M, an increase of 861.63%. That is a compound annual growth rate of 17.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 222.31M | 1,413.29% |
| Dec 31, 2025 | 14.69M | -52.59% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 238.13M |
| Achieve Life Sciences | 234.23M |
| Keros Therapeutics | 230.89M |
| MediWound | 223.62M |
| Protalix BioTherapeutics | 223.57M |
| Alector | 220.17M |
| Sol-Gel Technologies | 220.08M |
| Voyager Therapeutics | 218.51M |